- With Mayo Clinic psychiatrist
David Mrazek, M.D.
read biographyclose windowBiography of
David Mrazek, M.D.
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
- Complexity of depression diagnosis makes treatment difficult
March 8, 2012
- Depression sometimes shifts to bipolar disorder
Jan. 21, 2012
- Antidepressant use soaring among Americans 12 and over
Dec. 7, 2011
- Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
- New antidepressant offers hope
Sept. 3, 2011
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Depression blog
-
Nov. 25, 2008
Depression and pregnancy
By David Mrazek, M.D.
| Need more help? |
|
Pregnancy is a joyous occasion. Pregnancy, though, does not protect women from experiencing mild to severe depression. Medication and/or therapy may be recommended.
Treating depression is always important and it can be successfully treated during and after pregnancy. Some antidepressant/antianxiety medications can be used safely throughout pregnancy and breast feeding.
Paxil (generic name Paroxetine) has been shown to cause cardiac malformations in the fetus and absolutely should not be used during the first trimester of pregnancy. There is no evidence that children have harmful long-term effects as a result of their mother taking antidepressant medication during pregnancy.
No medication is 100 percent safe during pregnancy, but some are safer than others. Mood stabilizers generally are not safe during pregnancy. If you have been diagnosed with bipolar affective disorder, discuss this with your health care provider.
Untreated depression during pregnancy has been proven to lead to higher rates of:
- Lower birth weights
- Pre-term labor (depression doubles the risk)
- Increased use of alcohol and drugs to self-medicate
Please have a candid discussion with both your psychiatrist and OB-GYN regarding the benefits, risks and side effects of all medications. If you have been diagnosed with depression and are considering pregnancy, meet with your health providers before you get pregnant. This will provide peace of mind and help to make sure that you and your baby are both as healthy as possible.
Please share your experiences.
4 comments posted
Share on:
4 comments posted